This invention describes a specially optimized strain of bacteria called *Nitrosomonas eutropha* D23. This particular bacterium is designed to produce more nitric oxide and its precursors, and to suppress the growth of harmful bacteria. It is intended for use in treating conditions like low nitrite levels, various skin diseases, and infections caused by pathogenic bacteria. The invention specifically refers to a bacterium identified by ATCC accession number PTA-121157 or having a circular genome with SEQ ID NO: 1.
Why it matters: Since 2020, advancements in microbiome research and live biotherapeutic development have deepened understanding of specific bacterial strain interactions, potentially refining applications for this probiotic.
AI gives you a few directions you could take this. Pick one, and we check whether your version is different enough to patent, then write the filing.
Reinvent this with AI